What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study-Reference-Cited by-同舟云学术

What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study

Published:2014-06-16 Issue:6 Volume:9 Page:e98933
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Smelt Antonia F. H.,Louter Mark A.,Kies Dennis A.,Blom Jeanet W.,Terwindt Gisela M.,van der Heijden Geert J. M. G.,De Gucht Véronique,Ferrari Michel D.,Assendelft Willem J. J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference13 articles.

1. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators;P Tfelt-Hansen;Cephalalgia,2012

2. What do patients with migraine want from acute migraine treatment;RB Lipton;Headache,2002

3. An assessment of the burden of migraine using the willingness to pay model;SW Hamelsky;Cephalalgia,2005

4. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda;JV Selby;JAMA,2012

5. Qualitative research: consensus methods for medical and health services research;J Jones;BMJ,1995

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome;Neurology;2024-09-24

2. Neues aus der Akuttherapie der Migräne;Fortschritte der Neurologie · Psychiatrie;2024-06-12

3. Safety, tolerability, and pharmacokinetics of a single orally inhaled dose of PUR3100, a dry powder formulation of dihydroergotamine versus intravenous dihydroergotamine: A Phase 1 randomized, double‐blind study in healthy adults;Headache: The Journal of Head and Face Pain;2024-05-08

4. Long-Term Use of Rimegepant 75 mg for the Acute Treatment of Migraine is Associated with a Reduction in the Utilization of Select Analgesics and Antiemetics;Journal of Pain Research;2024-05

5. Correlation of effectiveness and tolerability assessments from a pharmacy-based observational study investigating the fixed-dose combination of 400 mg ibuprofen plus 100 mg caffeine for the treatment of acute headache;Frontiers in Neurology;2023-10-24